All In MedTech

FDA Clearance Tracker · K170951

CardioCel 3D

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Apr 28, 2017 (this decision)Source: openFDAMethods & limitations

510(k)First of its product code

Decided

Apr 28, 2017

Substantially Equivalent

Time to decision

28 days

Received Mar 31, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Special

Device class

Class II

The decision

FDA number
K170951
Device name
CardioCel 3D
Applicant location
Malaga, AU
Received
Mar 31, 2017
Decided
Apr 28, 2017
Decision
Substantially Equivalent
Submission type
Special

Device type

Device class
Class II
Regulation
21 CFR 870.3470
Specialty
Cardiology

Every decision under product code PSQ

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code PSQ (Intracardiac Patch Or Pledget, Biologically Derived).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Admedus Regen Pty, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.